收藏切换
Applications of built-in adjuvants in anti-tumor carbohydrate and glycopeptide vaccines
收藏切换
Ru-yan ZHANG1, Yu WEN2, Wen-xiang ZHAO1, Zhen-hong SU1, Jing-jing DU1, *, Jun GUO2, *
Acta Pharmaceutica Sinica | 2025, 60(7) : 2002 - 2015
Less
收藏切换
Acta Pharmaceutica Sinica | 2025, 60(7): 2002-2015
• Special Reports: Research progress and development trend of carbohydrate-based vaccines •
Applications of built-in adjuvants in anti-tumor carbohydrate and glycopeptide vaccines
Full
Ru-yan ZHANG1, Yu WEN2, Wen-xiang ZHAO1, Zhen-hong SU1, Jing-jing DU1, *, Jun GUO2, *
Affiliations
  • 1Hubei Key Laboratory for Kidney Disease Pathogenesis and Intervention, College of Medicine, Hubei Polytechnic University, Huangshi 435003, China
  • 2International Joint Research Center for Intelligent Biosensing Technology and Health, National Key Laboratory of Green Pesticide, College of Chemistry, Central China Normal University, Wuhan 430079, China
Published: 2025-07-12 doi: 10.16438/j.0513-4870.2025-0337
Outline
收藏切换

Carbohydrate and glycopeptide vaccines have shown great promise in tumor prevention and treatment. However, their relatively low immunogenicity remains a significant challenge. To address this, adjuvants are commonly employed to enhance immune responses against specific antigens. Despite their widespread use, conventional adjuvants still face several limitations, including limited immune stimulation and potential safety concerns associated with molecular diffusion. A promising strategy to overcome these challenges is the incorporation of built-in adjuvants, which promotes adjuvants to augment their immunostimulatory effect. This review highlights the application of various immune agonists as built-in adjuvants to enhance vaccine immunogenicity, including Toll-like receptor (TLR) agonists, invariant natural killer T (iNKT) cell agonists, stimulator of interferon genes (STING) agonists, nucleotide-binding oligomerization domain-like receptors (NLR) agonists, and C-type lectin receptor (CLR) agonists. By summarizing recent advancements in this field, we provide valuable insights into the development of more effective and safer carbohydrate vaccines.

anti-tumor vaccine  /  adjuvant-antigen conjugate  /  carbohydrate antigen  /  glycopeptide antigen  /  immunotherapy
张如岩, 文雨, 赵文翔, 苏振宏, 杜晶晶, 郭军. 内嵌佐剂在肿瘤糖疫苗及糖肽疫苗中的应用. 药学学报, 2025 , 60 (7) : 2002 -2015 . DOI: 10.16438/j.0513-4870.2025-0337
Ru-yan ZHANG, Yu WEN, Wen-xiang ZHAO, Zhen-hong SU, Jing-jing DU, Jun GUO. Applications of built-in adjuvants in anti-tumor carbohydrate and glycopeptide vaccines[J]. Acta Pharmaceutica Sinica, 2025 , 60 (7) : 2002 -2015 . DOI: 10.16438/j.0513-4870.2025-0337
Year 2025 volume 60 Issue 7
288
145
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2025-0337
  • Receive Date:2025-03-29
  • Online Date:2026-09-20
  • Published:2025-07-12
Article Data
Affiliations
History
  • Received:2025-03-29
  • Revised:2025-06-09
Affiliations
    1Hubei Key Laboratory for Kidney Disease Pathogenesis and Intervention, College of Medicine, Hubei Polytechnic University, Huangshi 435003, China
    2International Joint Research Center for Intelligent Biosensing Technology and Health, National Key Laboratory of Green Pesticide, College of Chemistry, Central China Normal University, Wuhan 430079, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2025-0337
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT